MARQIBO KIT Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Marqibo Kit, and when can generic versions of Marqibo Kit launch?
Marqibo Kit is a drug marketed by Acrotech and is included in one NDA.
The generic ingredient in MARQIBO KIT is vincristine sulfate. There are thirteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the vincristine sulfate profile page.
Summary for MARQIBO KIT
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 48 |
Clinical Trials: | 30 |
Patent Applications: | 4,535 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for MARQIBO KIT |
DailyMed Link: | MARQIBO KIT at DailyMed |
Recent Clinical Trials for MARQIBO KIT
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Medical College of Wisconsin | Phase 1 |
Dorothy Sipkins, MD, PhD | Phase 2 |
Acrotech Biopharma LLC | Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for MARQIBO KIT
US Patents and Regulatory Information for MARQIBO KIT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Acrotech | MARQIBO KIT | vincristine sulfate | INJECTABLE, LIPOSOMAL;INTRAVENOUS | 202497-001 | Aug 9, 2012 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for MARQIBO KIT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Acrotech | MARQIBO KIT | vincristine sulfate | INJECTABLE, LIPOSOMAL;INTRAVENOUS | 202497-001 | Aug 9, 2012 | ⤷ Try a Trial | ⤷ Try a Trial |
Acrotech | MARQIBO KIT | vincristine sulfate | INJECTABLE, LIPOSOMAL;INTRAVENOUS | 202497-001 | Aug 9, 2012 | ⤷ Try a Trial | ⤷ Try a Trial |
Acrotech | MARQIBO KIT | vincristine sulfate | INJECTABLE, LIPOSOMAL;INTRAVENOUS | 202497-001 | Aug 9, 2012 | ⤷ Try a Trial | ⤷ Try a Trial |
Acrotech | MARQIBO KIT | vincristine sulfate | INJECTABLE, LIPOSOMAL;INTRAVENOUS | 202497-001 | Aug 9, 2012 | ⤷ Try a Trial | ⤷ Try a Trial |
Acrotech | MARQIBO KIT | vincristine sulfate | INJECTABLE, LIPOSOMAL;INTRAVENOUS | 202497-001 | Aug 9, 2012 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for MARQIBO KIT
See the table below for patents covering MARQIBO KIT around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Spain | 2333400 | ⤷ Try a Trial | |
Spain | 2206510 | ⤷ Try a Trial | |
Germany | 69531701 | ⤷ Try a Trial | |
Japan | H10501534 | ⤷ Try a Trial | |
Israel | 145720 | USE OF A LIPOSOME ENCAPSULATED VINCRISTINE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR TREATING CANCER | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |